1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Fumaric aciduria: new trials by email Literature Review of Fumaric aciduria trials Research Report on Fumaric aciduria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma Sintilimab injection plus Inlyta treatment - Carcinoma, Renal Cell, Fumarate Hydratase Deficiency | Phase 2 | Unknown | West China Hospital | 41 | 2021-07-01 | 2024-04-09 |
| An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy 13C-Glucose, 13C-Acetate, 13C-Lactate - Kidney Cancer, Renal Cell Carcinoma | Not applicable | Recruiting | University of Texas Southwestern Medical Center | 600 | 2019-09-30 | 2026-01-28 |
Carcinoma, Renal Cell (2) · Adenocarcinoma, Clear Cell (1) · Carcinoma, Transitional Cell (1) · Hereditary leiomyomatosis and renal cell cancer (1) · Kidney Neoplasms (1)
Adenocarcinoma (2) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2) · Kidney Neoplasms (1)
sintilimab (1)
University of Texas Southwestern Medical Center (1) · West China Hospital (1)
China (1) · United States (1)
Hao Zeng (1) · Vitaly Margulis, MD (1)
F31CA239330 (1), P50CA196516 (1), R35CA220449 (1)